相关实验视频

Updated: Mar 8, 2026

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma

Published on: June 10, 2017

双SORT LNP用于多机关数据库编辑

Minjeong Kim¹, Eunice S Song¹, Joseph C Chen²

¹Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, TX, USA.

Nature biotechnology

|June 2, 2025

概括

双选择性器官向性脂质纳米颗粒 (SORT LNPs) 为阿尔法-1抗素缺乏症 (AATD) 提供了潜在的治疗方法. 这种疗法成功地纠正了肝脏和肺细胞中的PiZ突变,为这种多器官疾病提供了有希望的长期基因组纠正.

科学领域:

遗传学和基因组学在
纳米技术纳米技术
基因治疗基因治疗

背景情况:

阿尔法-1抗素缺乏症 (AATD) 源于SERPINA1基因突变,导致肝损伤和肺气.
目前对AATD的治疗方法有限,需要新的治疗策略.
有效的AATD治疗需要针对肝脏和肺部,这是一个挑战.

研究的目的:

为基础编辑开发一个双重目标的交付系统来解决AATD.
创建双选择性器官向性脂质纳米颗粒 (SORT LNPs) 以同时输送肝脏和肺部.
评估SORT LNP提供的基编辑在纠正导致AATD的突变方面的有效性.

主要方法:

开发双SORT LNP,以有针对性地交付基础编辑器.
用双SORT LNP来纠正肝脏和肺细胞中的PiZ突变.
评估基因编辑效率,Z-A1AT水平,肝脏表型和中性粒细胞弹性酶活性.

主要成果:

双SORT LNP在肝细胞中实现了40%的编辑,在肺AT2细胞中达到10%.
稳定的肝脏编辑维持了32周,减少了80%以上的Z-A1AT,并恢复了正常的肝脏表型.
在肺部支气管支气管洗液中观察到显著的中性粒细胞弹性酶抑制 (89%).

结论:

双SORT LNP疗法在临床前模型中证明了对AATD的有效基因组校正.
这种方法为治疗像AATD这样的多器官遗传疾病提供了一个有希望的策略.
开发的双目标输送系统显示了长期治疗效果的潜力.

更多相关视频

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

Establishment, Maintenance, Differentiation, Genetic Manipulation, and Transplantation of Mouse and Human Lacrimal Gland Organoids

Establishment, Maintenance, Differentiation, Genetic Manipulation, and Transplantation of Mouse and Human Lacrimal Gland Organoids

Published on: February 3, 2023

相关概念视频

Long-patch Base Excision Repair

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...